Title : A phase II study of biweekly paclitaxel and cisplatin chemotherapy for recurrent or metastatic esophageal squamous cell carcinoma: ERCC1 expression predicts response to chemotherapy.

Pub. Date : 2013 Mar

PMID : 23263828






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Our study indicates that the expression of ERCC1 evaluated by immunohistochemistry is a promising predictive marker for response in patients with metastatic ESCC receiving cisplatin-paclitaxel regimen. Cisplatin ERCC excision repair 1, endonuclease non-catalytic subunit Homo sapiens